A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors
Carducci, Michael, Shaheen, Montaser, Markman, Ben, Hurvitz, Sara, Mahadevan, Daruka, Kotasek, Dusan, Goodman, Oscar B., Rasmussen, Erik, Chow, Vincent, Juan, Gloria, Friberg, Gregory R., Gamelin, Erick, Vogl, Florian D., Desai, Jayesh
Published in Investigational new drugs (01.12.2018)
Published in Investigational new drugs (01.12.2018)
Get full text
Journal Article
Abstract CT045: Phase 1, open-label, first-in-human study of AMG 900, an orally administered pan-aurora kinase inhibitor, in adult patients (pts) with advanced solid tumors
Shaheen, Montasser, Markman, Ben, Carducci, Michael, Hurvitz, Sara, Mahadevan, Daruka, Kotasek, Dusan, Goodman, Oscar, Gamelin, Erick, Chow, Vincent, Juan, Gloria, Rasmussen, Erik, Friberg, Gregory R., Vogl, Florian D., Desai, Jayesh
Published in Cancer research (Chicago, Ill.) (15.07.2016)
Published in Cancer research (Chicago, Ill.) (15.07.2016)
Get full text
Journal Article
A first-in-human study of AMG 780, an angiopoietin-1 and -2 (ANG1/2) inhibitor, in patients (pts) with advanced solid tumors
Dowlati, Afshin, Vlahovic, Gordana, Natale, Ronald B., Rasmussen, Erik, Singh, Indrajeet, Hwang, Yuying C., Rossi, John, Bass, Michael B., Friberg, Gregory R., Pickett-Gies, Cheryl Ann
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Evaluation of pharmacokinetic (PK) drug-drug interactions (DDI) between trebananib (AMG 386) and paclitaxel (PTX) in patients (pts) with advanced solid tumors
Diamond, Jennifer Robinson, Agarwal, Neeraj, Bowles, Daniel W., Lam, Elaine Tat, Werner, Theresa Louise, Wu, Benjamin, Rasmussen, Erik, Gamelin, Erick, Soto, Felipe, Friberg, Gregory R., Sun, Yu-Nien, Sharma, Sunil
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
First-in-human study of AMG 900, an oral pan-Aurora kinase inhibitor, in adult patients (pts) with advanced solid tumors
Carducci, Michael Anthony, Shaheen, Montaser F., Paller, Channing Judith, Bauman, Julie E., Azad, Nilofer Saba, Shubhakar, Poornima, Tang, Rui, Stroh, Mark, Friberg, Gregory R., Verschraegen, Claire F.
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
An EGFRvIII-specific IHC IUO test for patient selection in AMG 595 phase I trial
Damore, Michael A., Coberly, Suzanne K., Wakamiya, Karen, Webster, Scott, Tanna, Vaishali, Xu, Xiaolei, Klement, Ivan, Welcher, Rosanne, Kiaei, Panteha, Liu, Yi, Samayoa, Kimberly, Wong, Susan, Shamon-Taylor, Lisa, Friberg, Gregory R., Hill, John S., Patterson, Scott D.
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article